Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PDE2A Antikörper (C-Term)

PDE2A Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, IP, CM, ICC, FRET Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2747086
  • Target Alle PDE2A Antikörper anzeigen
    PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
    Bindungsspezifität
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    AA 875-925, C-Term
    Reaktivität
    • 29
    • 22
    • 21
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    Human, Maus, Ratte
    Wirt
    • 29
    • 3
    Kaninchen
    Klonalität
    • 30
    • 2
    Polyklonal
    Konjugat
    • 16
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PDE2A Antikörper ist unkonjugiert
    Applikation
    • 20
    • 17
    • 12
    • 9
    • 8
    • 5
    • 5
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Confocal Microscopy (CM), Immunocytochemistry (ICC), Fluorescence Resonance Energy Transfer Microscopy (FRET)
    Aufreinigung
    Affinity Purified
    Immunogen
    Synthetic peptide taken within amino acid region 875-925 on human PDE2A protein. Will label all PD2A variants.
    Isotyp
    IgG
    Top Product
    Discover our top product PDE2A Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.7 μg/μL
  • Fields, Koschinski, Zaccolo: "Sustained exposure to catecholamines affects cAMP/PKA compartmentalised signalling in adult rat ventricular myocytes." in: Cellular signalling, Vol. 28, Issue 7, pp. 725-32, (2017) (PubMed).

    Pathak, Agostino, Bishara, Capell, Fisher, Hegde, Ibrahim, Pilarzyk, Sabin, Tuczkewycz, Wilson, Kelly: "PDE11A negatively regulates lithium responsivity." in: Molecular psychiatry, Vol. 22, Issue 12, pp. 1714-1724, (2017) (PubMed).

    Vettel, Lindner, Dewenter, Lorenz, Schanbacher, Riedel, Lämmle, Meinecke, Mason, Sossalla, Geerts, Hoffmann, Wunder, Brunner, Wieland, Mehel, Karam, Lechêne, Leroy, Vandecasteele, Wagner et al.: "Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction." in: Circulation research, Vol. 120, Issue 1, pp. 120-132, (2017) (PubMed).

    Sprenger, Perera, Steinbrecher, Lehnart, Maier, Hasenfuss, Nikolaev: "In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease." in: Nature communications, Vol. 6, pp. 6965, (2016) (PubMed).

    Hiramoto, Murata, Shimizu, Morita, Inui, Manganiello, Tagawa, Arai: "Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells." in: Cellular signalling, Vol. 26, Issue 9, pp. 1807-17, (2015) (PubMed).

    Rentsendorj, DAlessio, Pearse: "Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages." in: Journal of leukocyte biology, Vol. 96, Issue 5, pp. 907-15, (2015) (PubMed).

    Rajagopal, Nalli, Kumar, Bhattacharya, Hu, Mahavadi, Grider, Murthy: "Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation." in: The Journal of pharmacology and experimental therapeutics, Vol. 352, Issue 3, pp. 509-18, (2015) (PubMed).

    Petersen, Kristensen, Jeppesen, Grøndahl, Wissing, Macklon, Andersen: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).

    Kedia, Ückert, Oelke, Sonnenberg, Sohn, Kuczyk, Hedlund: "Expression and distribution of phosphodiesterase isoenzymes in the human male urethra." in: Urology, Vol. 85, Issue 4, pp. 964.e1-6, (2015) (PubMed).

    Zhai, Chang, Wei, Liu, Leblais, Fischmeister, Ji: "Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms." in: Cellular signalling, Vol. 26, Issue 5, pp. 1001-10, (2014) (PubMed).

    Yougbaré, Keravis, Abusnina, Decossas, Schall, Muller, Lugnier: "Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling." in: Biochimica et biophysica acta, Vol. 1842, Issue 7, pp. 916-26, (2014) (PubMed).

    Stephenson, Coskran, Kelly, Kleiman, Morton, ONeill, Schmidt, Weinberg, Menniti: "The distribution of phosphodiesterase 2A in the rat brain." in: Neuroscience, Vol. 226, pp. 145-55, (2013) (PubMed).

    Ückert, Oelke, Albrecht, Breitmeier, Kuczyk, Hedlund: "Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5)." in: International journal of impotence research, Vol. 23, Issue 5, pp. 206-12, (2012) (PubMed).

    Matsuo, Rossier, Kan, Rodriguez: "The wiring of Grueneberg ganglion axons is dependent on neuropilin 1." in: Development (Cambridge, England), Vol. 139, Issue 15, pp. 2783-91, (2012) (PubMed).

    Lin, Fretier, Jiang, Vincent: "Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons." in: Synapse (New York, N.Y.), Vol. 64, Issue 6, pp. 460-6, (2010) (PubMed).

    van der Horst, Morgan, Eaton, Reiss, Tibboel, Thébaud: "Expression and function of phosphodiesterases in nitrofen-induced congenital diaphragmatic hernia in rats." in: Pediatric pulmonology, Vol. 45, Issue 4, pp. 320-5, (2010) (PubMed).

    Witzenrath, Gutbier, Schmeck, Tenor, Seybold, Kuelzer, Grentzmann, Hatzelmann, van Laak, Tschernig, Mitchell, Schudt, Rosseau, Suttorp, Schütte: "Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia." in: Critical care medicine, Vol. 37, Issue 2, pp. 584-90, (2009) (PubMed).

    Spiessberger, Bernhard, Herrmann, Feil, Werner, Luppa, Hofmann: "cGMP-dependent protein kinase II and aldosterone secretion." in: The FEBS journal, Vol. 276, Issue 4, pp. 1007-13, (2009) (PubMed).

    Liu, Fraser, Koos: "Grueneberg ganglion olfactory subsystem employs a cGMP signaling pathway." in: The Journal of comparative neurology, Vol. 516, Issue 1, pp. 36-48, (2009) (PubMed).

    Walz, Feinstein, Khan, Mombaerts: "Axonal wiring of guanylate cyclase-D-expressing olfactory neurons is dependent on neuropilin 2 and semaphorin 3F." in: Development (Cambridge, England), Vol. 134, Issue 22, pp. 4063-72, (2008) (PubMed).

  • Target
    PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
    Andere Bezeichnung
    PDE2A (PDE2A Produkte)
    Synonyme
    PDE2A antikoerper, CGS-PDE antikoerper, PDE2A1 antikoerper, PED2A4 antikoerper, cGSPDE antikoerper, Pde2 antikoerper, Pde2a2 antikoerper, phosphodiesterase 2A antikoerper, phosphodiesterase 2A, cGMP-stimulated antikoerper, PDE2A antikoerper, pde2a antikoerper, Pde2a antikoerper
    Pathways
    cAMP Metabolic Process, Synaptic Membrane
Sie sind hier:
Kundenservice